Harrow Health (HROW) Misses Q1 EPS by 56c

Harrow Health (NASDAQ: HROW) reported Q1 EPS of ($0.50), $0.56 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $47.8 million versus the consensus estimate of $61.13 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Freedom Broker Double Downgrades Mosaic (MOS) to Sell
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters